You searched for
We found 9 articles

Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-Positive Lymphomas (EPL)

This trial will use a new method of treating lymphoma using a therapy derived from a person's Killer T cells.

01 Jan 2013

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin’s or Non-Hodgkin’s Lymphoma

Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who…

01 Jan 2013

PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin

This clinical research study is to investigate the prevention of relapse in patients with diffuse large B cell lymphoma (DLBCL)…

01 Jan 2013

Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin’s Lymphoma or Acute Lymphoblastic Leukemia

This phase II trial is studying how well rituximab together with ifosfamide, carboplatin, and etoposide works in treating young patients…

01 Jan 2013

IMVP-16/Pd followed by HDC/ASCT for relapsed peripheral T-cell lymphomas

Aim: To analyse the treatment outcome of IMVP-16/Pd (ifosfamide, methotrexate, etoposide and prednisone) followed by high-dose chemotherapy and autologous stem…

01 Jan 2013

R-GIFOX for Relapsed and Refractory Aggressive Non-Hodgkin’s Lymphoma

Aim: To evaluate the clinical activity, toxicity and mobilizing capacity of a new short-course (bi-weekly), dose intensive, cytoreductive/mobilizing salvage regimen…

01 Jan 2013

Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI

Aim: To explore a more effective treatment for newly-diagnosed localized nasal NK/T-cell lymphoma, we conducted a multicenter phase I/II…

01 Jan 2013

HD Chemoradiotherapy and ASCT Can Overcome the Prognostic Importance of Bcl-2, Bim, and p53 in Relapsed/Refractory Hodgkin’s Lymphoma

Aim: Prior studies showed that overexpression of bcl-2 and p53 have negative impact on outcome with primary therapy. The…

01 Jan 2013

The Utility of Consolidative Upfront High Dose Chemoradiotherapy and ASCT in Patients with Mantle Cell Lymphoma (MCL)

Aim: To improve progression-free survival (PFS) in MCL using a strategy of incorporating approaches of intensifying induction & intensifying…

01 Jan 2013